Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.lalchandanipathlab.com | |
Market Cap | 9.73 Cr. | |
Enterprise Value(EV) | 16.02 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.60 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 63.18 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 20.56 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.09 | Calculated using Price: 22.45 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.43 Cr. | 4,333,068 Shares |
FaceValue | 10 | |
About Dr Lalchandani Labs Ltd. | ||
They are a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through their integrated network, they offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. |
1 Day |
|
-19.82% |
1 Week |
|
-35.86% |
1 Month |
|
-31.35% |
3 Month |
|
-18.66% |
6 Month |
|
-6.46% |
1 Year |
|
-12.82% |
2 Year |
|
-50.55% |
5 Year |
|
+0.90% |
10 Year |
|
6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 8.11 | 9.85 | 6.01 | 11.56 | 9.49 | -16.23 | |
Return on Capital Employed (%) | 10.06 | 12.57 | 9.17 | 14.88 | 13.07 | -3.69 | |
Return on Assets (%) | 4.23 | 6.53 | 4.30 | 7.46 | 5.60 | -8.72 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3 | 8 | 9 | 10 | 10 | 9 | 9 | |
Non Curr. Liab. | 1 | 1 | 2 | 3 | 3 | 3 | 3 | |
Curr. Liab. | 2 | 1 | 2 | 3 | 5 | 5 | 5 | |
Minority Int. | ||||||||
Equity & Liab. | 6 | 10 | 12 | 15 | 18 | 18 | 17 | |
Non Curr. Assets | 2 | 4 | 4 | 6 | 7 | 7 | 6 | |
Curr. Assets | 4 | 6 | 8 | 9 | 11 | 11 | 11 | |
Misc. Exp. not W/O | 0 | 0 | 0 | 0 | 0 | |||
Total Assets | 6 | 10 | 12 | 15 | 18 | 18 | 17 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 3 | 5 | 6 | 10 | 11 | 5 | |
Other Income | 0 | 0 | |||||
Total Income | 3 | 5 | 6 | 10 | 11 | 5 | |
Total Expenditure | -2 | -4 | -5 | -8 | -9 | -5 | |
PBIDT | 1 | 1 | 1 | 2 | 2 | 0 | |
Interest | 0 | 0 | 0 | 0 | -1 | -1 | |
Depreciation | 0 | 0 | 0 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | 0 | ||
Exceptional Items | |||||||
PAT | 0 | 1 | 0 | 1 | 1 | -2 | |
Adjusted EPS | 1 | 1 | 1 | 2 | 2 | -4 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 0 | 0 | 1 | 2 | ||
Cash Fr. Inv. | -1 | -2 | -1 | -2 | -2 | 0 | |
Cash Fr. Finan. | 2 | 4 | 1 | 2 | 0 | 0 | |
Net Change | 1 | 1 | 0 | 1 | 1 | 0 | |
Cash & Cash Eqvt | 1 | 2 | 2 | 3 | 4 | 3 |
Fri, 01 Dec 2023
Appointment of Company Secretary and Compliance Officer Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023 |
Mon, 27 Nov 2023
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Resignation of Ms. Monika Joshi as Company and Compliance Officer |
Tue, 14 Nov 2023
Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 30 2023 unaudited financial results for September 2023 |
Mon, 11 Dec 2023 |
|
|
|
|
|